BAY 11-7082 ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated oxidative stress and renal inflammation via NF-κB pathway-Reference-Cited by-同舟云学术

BAY 11-7082 ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated oxidative stress and renal inflammation via NF-κB pathway

Published:2015-03 Issue:2 Volume:39 Page:690-699
ISSN:1382-6689
Container-title:Environmental Toxicology and Pharmacology
language:en
Short-container-title:Environmental Toxicology and Pharmacology

Author:

Kolati Sambasiva Rao,Kasala Eshvendar Reddy^ORCID,Bodduluru Lakshmi Narendra,Mahareddy Jalandhar Reddy,Uppulapu Shravan Kumar,Gogoi Ranadeep,Barua Chandana C.,Lahkar Mangala

Publisher

Elsevier BV

Subject

Health, Toxicology and Mutagenesis,Pharmacology,Toxicology,General Medicine

Reference42 articles.

1. Role of Smad1 in diabetic nephropathy: molecular mechanisms and implications as a diagnostic marker;Abe;Histol. Histopathol.,2011

2. Protective effect of herbomineral formulation (Dolabi) on early diabetic nephropathy in streptozotocin-induced diabetic rats;Baig;J. Nat. Med.,2012

3. NF-κB, inflammation, and metabolic disease;Baker;Cell Metab.,2011

4. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases;Barnes;N. Engl. J. Med.,1997

5. The effect of 3-methyladenine DNA glycosylase-mediated DNA repair on the induction of toxicity and diabetes by the beta-cell toxicant streptozotocin;Burns;Toxicol. Sci.,2007

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Insights on NLRP3 Inflammasome: Mechanisms of Activation, Inhibition, and Epigenetic Regulation;Journal of Neuroimmune Pharmacology;2024-02-29

2. EFFECT OF HYPEROSIDE ON KLOTHO PROTEIN IN RATS WITH CHRONIC RENAL FAILURE;FARMACIA;2024

3. Advances in understanding and treating diabetic kidney disease: focus on tubulointerstitial inflammation mechanisms;Frontiers in Endocrinology;2023-10-04

4. Pyroptosis in renal inflammation and fibrosis: current knowledge and clinical significance;Cell Death & Disease;2023-07-27

5. Metaflammation in glucolipid metabolic disorders: Pathogenesis and treatment;Biomedicine & Pharmacotherapy;2023-05